A human study to evaluate the effectiveness and safety of CAA on the fatigue improvement

Not Applicable

Completed

• Conditions: Not Applicable

• Registration Number: KCT0005613
• Lead Sponsor: Seoul National University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2022-01-27
• Last Update Posted: 24 October 2022

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

1) Subject who voluntarily agrees to participate and sign in informed consent form
2) Healthy adults aged 30 to under 60 who complain of fatigue

Exclusion Criteria

1) Subject who is unable to perform cycle ergometer test
2) Subject who constantly exercised for 3 months prior to the first visit
3) Those with a high level of cardiopulmonary endurance
4) Subject has a body mass index (BMI) of 18.5 kg / m2 or less or 30.0kg / m2 or more
5) Subject is over alcoholic
: Men > 210g/week, Women > 140g/week
6) Smoker and drug addict
7) Insomnia
8) Subject have any of the following (including past medical history) or are taking any related medicines: hyperlipidemia, asthma, musculoskeletal disorder and etc
9) Subject who had a surgical operation 6 months prior to the first visit
10) Subjects who consumed oriental medicine within 1 month prior to the first visit
11) Subjects who consumed functional foods or related food to affect physical performance and fatigue
12) A person who continuously used a fatigue recovery injection within one month of his/her first visit.
13) Subject with hypersensitivity to the test food or ingredients contained in the test food
14) Pregnant or lactating women or person who has pregnancy plan during the study
15) Subject in other clinical trials within one month of the first visit or plan to participate in other clinical trials during this human study period
16) Subject unable to use smartphone or computer
17) Any condition that the principal investigator believes may put the subjects at undue risk

Study & Design

• Study Type: Interventional Study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
fatigue related indicators

Secondary Outcome Measures

Name	Time	Method
Clinical pathology examination(Vital sings, clinical laboratory test)